Murat İşbilen
Murat İşbilen
PhD Student, Acibadem University
Verified email at
Cited by
Cited by
RETRACTED ARTICLE: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
R Hill, PA Madureira, B Ferreira, I Baptista, S Machado, L Colaco, ...
Nature communications 8 (1), 14687, 2017
Adjuvant autologous melanoma vaccine for macroscopic stage III disease: survival, biomarkers, and improved response to CTLA‐4 blockade
M Lotem, S Merims, S Frank, T Hamburger, A Nissan, L Kadouri, J Cohen, ...
Journal of immunology research 2016 (1), 8121985, 2016
A combined ULBP2 and SEMA5A expression signature as a prognostic and predictive biomarker for colon cancer
S Demirkol, I Gomceli, M Isbilen, BE Dayanc, M Tez, EB Bostanci, ...
Journal of Cancer 8 (7), 1113, 2017
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
S Turk, C Turk, MW Akbar, B Kucukkaraduman, M Isbilen, ...
PLoS One 15 (11), e0242497, 2020
A stemness and EMT based gene expression signature identifies phenotypic plasticity and is a predictive but not prognostic biomarker for breast cancer
MW Akbar, M Isbilen, N Belder, SD Canli, B Kucukkaraduman, C Turk, ...
Journal of Cancer 11 (4), 949, 2020
Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma
KM Senses, M Gonen, AR Barutcu, Z Kalaylioglu, M Isbilen, O Konu, ...
BMC Medical Genetics 14, 1-6, 2013
A novel 20-gene prognostic score in pancreatic adenocarcinoma
S Demirkol Canlı, E Dedeoğlu, MW Akbar, B Küçükkaraduman, M İşbilen, ...
PLoS One 15 (4), e0231835, 2020
Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma
KM Senses, M Ghasemi, MW Akbar, M Isbilen, AL Fallacara, ...
Medchemcomm 8 (1), 88-95, 2017
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT. Nat Commun 8: 14687
R Hill, PA Madureira, B Ferreira, I Baptista, S Machado, L Colaço, ...
Predicting chemotherapy sensitivity profiles for breast cancer cell lines with and without stem cell-like features
M Isbilen, K Mert Senses, A Osmay Gure
Current Signal Transduction Therapy 8 (3), 268-273, 2013
Predictive gene signature for pyrazolopyrimidine derivative c-Src inhibitor 10a sensitivity in melanoma cells
B Kucukkaraduman, C Turk, AL Fallacara, M Isbilen, KM Senses, ...
ACS Medicinal Chemistry Letters 11 (5), 928-932, 2020
Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma
H Akgun, S Metintas, G Ak, SD Canlı, M Isbilen, AO Gure, M Metintas
Archives of medical science: AMS 19 (2), 355, 2023
Plasticity as an underlying mechanism of tumor heterogeneity in breast cancer
MW Akbar, M Isbilen, B Kucukkaraduman, SD Canli, E Dedeoglu, ...
bioRxiv, 2020.03. 11.987511, 2020
Identification of Theranostic Gene Markers in Cancers and Prognostic Validation in Colorect Al Cancer
M İşbilen
PQDT-Global, 2015
Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues
IB Padzińska-Pruszyńska, MW Akbar, M Isbilen, E Górka, ...
International Journal of Molecular Sciences 25 (11), 6054, 2024
Six potential biomarkers for bladder cancer: key proteins in cell-cycle division and apoptosis pathways
G Inal Gültekin, Ö Timirci Kahraman, M Işbilen, S Durmuş, T Çakir, ...
Journal of the Egyptian National Cancer Institute 34 (1), 54, 2022
Investigation of Sensitivity to AZD7762 in Triple-Negative Breast Cancer (TNBC) with RBFOX2 Gene Expression as a Biomarker
IM Alkac, M Işbilen, B Küçükkaraduman, AO GÜRE, B Vural
Experimed 12 (2), 33-37, 2022
Targeting breast cancer stem cells
MW Akbar, M Isbilen, N Belder, S Demirkol, B Kucukkaraduman, O Sahin, ...
FEBS OPEN BIO 9, 320-321, 2019
P3. 03-039 Prognostic Biomarkers for Malignant Pleural Mesothelioma Treated with Chemotherapy: Topic: Mesothelioma Clinical
H Akgun, S Metintas, G Ak, S Demirkol, R Aydın, M Isbilen, A Gure, ...
Journal of Thoracic Oncology 12 (1), S1369, 2017
Clinical Study Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
M Lotem, S Merims, S Frank, T Hamburger, A Nissan, L Kadouri, J Cohen, ...
The system can't perform the operation now. Try again later.
Articles 1–20